Making decisions with real-world evidence and COVID-19
The COVID-19 pandemic has triggered intense and widespread action among the biopharma industry and...
HealthVerity Blog
- Read the latest insights from the HealthVerity team.
Search
Category
Popular Post
- The GLP-1 trend: What the real-world data reveals
- Open claims vs. closed payer claims: What’s the difference?
- GLP-1 trends 2025: real-world data, patient outcomes & future therapies
- What is Privacy Preserving Record Linkage (PPRL)?
- GLP‑1 real‑world data for obesity: A new standard for metabolic care
Subscribe
Why underpowered studies are more dangerous than you think
In epidemiology, statistical power determines whether a study can accurately detect an effect of a given size with a specified probability, typically 80% or higher. When studies fall below that threshold, the consequences extend well beyond inconclus...